• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.09% Nasdaq Up0.10%

    Bio-Reference Laboratories Inc. (BRLI)

    31.75 Up 0.02(0.07%) 11:30AM EST - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Bio-Reference Laboratories Inc.
    481 Edward H. Ross Drive
    Elmwood Park, NJ 07407
    United States - Map
    Phone: 201-791-2600
    Website: http://www.bioreference.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:3,338

    Business Summary 

    Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. The company offers chemical diagnostic tests, such as blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies), and other tissue analysis, as well as performs cancer cytogenetic testing. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. Bio-Reference Laboratories, Inc. provides its services directly to physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is headquartered in Elmwood Park, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Bio-Reference Laboratories Inc.

    Corporate Governance 
    Bio-Reference Laboratories Inc.’s ISS Governance QuickScore as of Dec 1, 2014 is 8. The pillar scores are Audit: 5; Board: 10; Shareholder Rights: 7; Compensation: 2.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Dr. Marc D. Grodman M.D., 62
    Founder, Chairman, Chief Exec. Officer, Pres and Managing Director
    Mr. Sam Singer , 70
    Chief Financial Officer, Chief Accounting Officer, Sr. VP and Director
    Mr. Howard Dubinett , 62
    Chief Operating Officer, Exec. VP and Director
    Dr. John Roglieri M.D., 75
    Director, Chairman of Compensation Committee, Chairman of Nominating Committee and Member of Audit Committee
    Ms. Wendy Chung ,
    Chief Scientific Officer
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders